$7.76
+0.30 (+4.02%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3.5% upside
Low Target
$5.28
Average Target
$8.03
High Target
$9.44
Current Price
$7.76
Current
$7.76
$7.76
Target
$8.03
$8.03
$5.28
$8.03 avg
$9.44
Scenario Analysis
Bear Case
$5.28
-32.0%
Low target
Base Case
$8.03
+3.5%
Avg target
Bull Case
$9.44
+21.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$8.41
-7.7% from high
52-Week Low
$3.72
+108.6% from low
Target vs 52W High
$8.03
-4.5% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
14d
until earnings
EPS Est: $-2.05
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |